NewsBenzingaInsmed relève ses prévisions de ventes pour l’exercice 2026 de 1,700 milliard à 1,870 milliard de dollars à 1,810 milliard à 1,870 milliard de dollars, contre une estimation de 1,801 milliard de dollars. Insmed relève ses prévisions de ventes pour l’exercice 2026 de 1,700 milliard à 1,870 milliard de dollars à 1,810 milliard à 1,870 milliard de dollars, contre une estimation de 1,801 milliard de dollars. Benzinga 2026.10.29 11:05 (GMT+0) Open on Benzinga Other news Ramp in Talks to Raise at Least $1 Billion at Valuation of Up to $75 Billion How Everyday Investors Are Playing the Nvidia Drama Curve: Fee Conversion Contract Loses $38.2K in Attack, Disabled With Replacement Planned Alvotech (ALVO) Presents at UBS Global Biopharma Conference 2026 Transcript Nvidia Tops Sales Forecast After Huang's Resignation Bill Gates Has Earned $2.6 Billion in Dividends From a Landfill Stock the EPA Keeps Citing for Methane Leaks, and a Filing Shows He Just Bought 3.7M More Shares
Bill Gates Has Earned $2.6 Billion in Dividends From a Landfill Stock the EPA Keeps Citing for Methane Leaks, and a Filing Shows He Just Bought 3.7M More Shares